Drs. Randy Hall and John Hepler Elected to ASPET Leadership Roles

The American Society for Pharmacology and Experimental Therapeutics (ASPET) held its annual elections recently and two members of the Emory Department of Pharmacology and Chemical Biology were voted into key leadership positions: Dr. Randy Hall will serve on the ASPET Council and Dr. John Hepler will serve as Chair of the Molecular Pharmacology Division of ASPET. The ASPET Council is a group of three individuals who work with the ASPET President to make key decisions regarding the direction of the Society. 

Dr. Hall will serve a three-year term as a Councilor.  He has served ASPET previously in a number of different leadership roles and is an internationally-renowned leader in the study of G protein-coupled receptors.

As Chair of the Molecular Pharmacology Division, Dr. Hepler will run one of the biggest divisions within ASPET and play a key role in determining programming for the Society’s annual meeting, amongst other duties.  He has previously served on the Executive Committee of the Molecular Pharmacology Division for a number of years and is an internationally-renowned leader in the study of G proteins and their regulators.

The Emory Department of Pharmacology and Chemical Biology has a long history of ASPET leadership.  Five faculty members from the department have served as ASPET President over the past 60 years, including most recently Eddie Morgan, who served as President in 2018-2019.